Progressi Cancer Immunotherapy Research ad Peking University
Et c180se princeps calor sterilization CO2 incubator factus est essentialis tool in ducens investigationis coetus ad Peking University Health Science Center (Pkuhsc), in progressionem provectus Cancer immunotherapies. In quadrigis investigat tumor-immune interactiones, aiming ad identify novae therapeutica scuta enim enhancing immune responsio in cancer aegris.
Et c180se incubator ensures a sterilis et firmum environment, offering precise temperatus imperium (± 0.1 ° C) et consistent CO2 campester, critica ad culturing immune et tumor cellulis. CXL ejus CXL æstus calor sterilization Minimizes contagione metus, maintaining integritas sensitivo cell culturas. Cum spatiosam thalamum facultatem et uniformis conditionibus, in incubator sustentans experimenta requiring reproducibility et altum cellulam viability.
Post tempus: Dec-27-2024